GLP-1 Receptor Agonist Use Linked to Lower Incidence of Obesity-Associated Cancers

THURSDAY, June 11, 2026-- For adults with obesity but without diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a significantly lower short-term incidence of obesity-associated cancers (OACs), according to a...